In HCC cells and tumor xenograft models, CD133+CD44+ cells (but not CD133+CD44-) display stem cell properties, including extensive proliferation, self-renewal capacity, tumorigenic potential, resistance to chemotherapy, and expression of stem cell-associated genes [91]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.